Xenon Pharmaceuticals Inc.
DE ˙ DB ˙ CA98420N1050
45,60 € ↑1,00 (2,24%)
2026-06-04
DEL PRIS
SecurityDE:XP0 / Xenon Pharmaceuticals Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership201,785 shares
Latest Disclosed Value $ 11,733,798
Millennium Management Llc ownership in XP0 / Xenon Pharmaceuticals Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 201,785 shares of Xenon Pharmaceuticals Inc. (DE:XP0) valued at $9,685,680 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 635,056 shares of Xenon Pharmaceuticals Inc.. This represents a change in shares of -68.23% during the quarter. The current value of the position is $9,201,396 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (XP0) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:XP0 / Xenon Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F XENON PHARMACEUTICALS COM 98420N105 201,785 -433,271 -68.23 11,734 -58.78 0.0049
2026-02-17 2025-12-31 13F XENON PHARMACEUTICALS COM 98420N105 635,056 -748,951 -54.11 28,463 -48.78 0.0120
2025-11-14 2025-09-30 13F XENON PHARMACEUTICALS COM 98420N105 1,384,007 501,172 56.77 55,568 101.10 0.0237
2025-08-14 2025-06-30 13F XENON PHARMACEUTICALS COM 98420N105 882,835 648,779 277.19 27,633 251.91 0.0133
2025-05-15 2025-03-31 13F XENON PHARMACEUTICALS COM 98420N105 234,056 -111,984 -32.36 7,853 -42.11 0.0042
2025-02-14 2024-12-31 13F XENON PHARMACEUTICALS COM 98420N105 346,040 137,014 65.55 13,565 64.83 0.0066
2024-11-14 2024-09-30 13F XENON PHARMACEUTICALS COM 98420N105 209,026 33,442 19.05 8,229 20.20 0.0039
2024-08-14 2024-06-30 13F XENON PHARMACEUTICALS COM 98420N105 175,584 91,923 109.88 6,846 90.11 0.0032
2024-05-15 2024-03-31 13F XENON PHARMACEUTICALS COM 98420N105 83,661 6,696 8.70 3,602 1.58 0.0015
2024-02-14 2023-12-31 13F XENON PHARMACEUTICALS COM 98420N105 76,965 -18,528 -19.40 3,545 8.68 0.0015
2023-11-14 2023-09-30 13F XENON PHARMACEUTICALS COM 98420N105 95,493 -117,845 -55.24 3,262 -60.28 0.0016
2023-08-14 2023-06-30 13F XENON PHARMACEUTICALS COM 98420N105 213,338 -8,132 -3.67 8,214 3.62 0.0041
2023-05-15 2023-03-31 13F XENON PHARMACEUTICALS COM 98420N105 221,470 -373,071 -62.75 7,926 -66.19 0.0045
2023-02-14 2022-12-31 13F XENON PHARMACEUTICALS COM 98420N105 594,541 34,192 6.10 23,443 15.89 0.0130
2022-11-14 2022-09-30 13F XENON PHARMACEUTICALS COM 98420N105 560,349 67,658 13.73 20,229 34.97 0.0120
2022-08-15 2022-06-30 13F XENON PHARMACEUTICALS COM 98420N105 492,691 356,365 261.41 14,988 259.68 0.0093
2022-05-16 2022-03-31 13F XENON PHARMACEUTICALS COM 98420N105 136,326 45,705 50.44 4,167 47.19 0.0022
2022-02-14 2021-12-31 13F XENON PHARMACEUTICALS COM 98420N105 90,621 -145,598 -61.64 2,831 -21.56 0.0014
2021-11-15 2021-09-30 13F XENON PHARMACEUTICALS COM 98420N105 236,219 -65,529 -21.72 3,609 -35.77 0.0022
2021-08-16 2021-06-30 13F XENON PHARMACEUTICALS COM 98420N105 301,748 -41,151 -12.00 5,619 -8.46 0.0034
2021-05-17 2021-03-31 13F XENON PHARMACEUTICALS COM 98420N105 342,899 -73,576 -17.67 6,138 -4.17 0.0044
2021-02-16 2020-12-31 13F XENON PHARMACEUTICALS COM 98420N105 416,475 297,630 250.44 6,405 386.70 0.0046
2020-11-16 2020-09-30 13F XENON PHARMACEUTICALS COM 98420N105 118,845 -49,151 -29.26 1,316 -37.54 0.0016
2020-08-14 2020-06-30 13F XENON PHARMACEUTICALS COM 98420N105 167,996 -25,573 -13.21 2,107 -4.01 0.0029
2020-05-14 2020-03-31 13F XENON PHARMACEUTICALS COM 98420N105 193,569 145,855 305.69 2,195 250.64 0.0049
2020-02-14 2019-12-31 13F XENON PHARMACEUTICALS COM 98420N105 47,714 47,714 626 0.0008
2019-08-15 2019-06-30 13F/A-1 XENON PHARMACEUTICALS COM 98420N105 0 -48,286 -100.00 0 -100.00
2019-05-14 2019-03-31 13F XENON PHARMACEUTICALS COM 98420N105 48,286 -97,096 -66.79 491 -46.46 0.0007
2019-02-15 2018-12-31 13F/A-1 XENON PHARMACEUTICALS COM 98420N105 145,382 62,509 75.43 917 -16.18 0.0014
2019-02-14 2018-12-31 13F XENON PHARMACEUTICALS COM 98420N105 145,382 917
2018-11-14 2018-09-30 13F XENON PHARMACEUTICALS COM 98420N105 82,873 -110,801 -57.21 1,094 -26.63 0.0013
2017-02-14 2016-12-31 13F XENON PHARMACEUTICALS COM 98420N105 193,674 193,674 1,491 0.0031
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F XENON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F XENON PHARMACEUTICALS COM Call 65,000 2,610 n/a n/a n/a
2024-02-14 2023-12-31 13F XENON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F XENON PHARMACEUTICALS COM Call 10,000 342 n/a n/a n/a
2022-02-14 2021-12-31 13F XENON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F XENON PHARMACEUTICALS COM Call 15,000 229 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-14 2023-12-31 13F XENON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F XENON PHARMACEUTICALS COM Put 45,000 1,537 n/a n/a n/a
2022-02-14 2021-12-31 13F XENON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F XENON PHARMACEUTICALS COM Put 45,000 688 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.